Therapeutic peptides and method

Details for Australian Patent Application No. 2005234705 (hide)

Owner Novo Nordisk A/S Universite Henri Poincare - Nancy 1

Inventors Faure, Gilbert; Gibot, Sebastien; Panina, Paola; Passini, Nadia

Agent Davies Collison Cave

Pub. Number AU-B-2005234705

Priority 0426146.7 29.11.04 GB; 2005-146848 19.05.05 JP

Filing date 21 November 2005

Wipo publication date 15 June 2006

Acceptance publication date 25 August 2011

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

8 December 2005 Complete Application Filed

  Priority application(s): 0426146.7 29.11.04 GB; 2005-146848 19.05.05 JP

15 June 2006 Application Open to Public Inspection

  Published as AU-B-2005234705

17 June 2010 Assignment before Grant

  BioXell SpA; Universite Henri Poincare - Nancy 1 The application has been assigned to Universite Henri Poincare - Nancy 1; Novo Nordisk A/S

25 August 2011 Application Accepted

  Published as AU-B-2005234705

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005234706-Height-adjustable support for semitrailers or the like

2005234704-Surface-deactivating composition for concrete or mortar comprising a nonionic surfactant